150 related articles for article (PubMed ID: 37142185)
1. Clinical Characteristics Associated with Musculoskeletal Extracutaneous Manifestations in Pediatric and Adult Morphea: A Prospective, Cohort Study.
Chen HW; Walker AM; Stein AB; Chen SL; Schollaert-Fitch KL; Torok KS; Jacobe HT
J Invest Dermatol; 2023 Oct; 143(10):1955-1963.e3. PubMed ID: 37142185
[TBL] [Abstract][Full Text] [Related]
2. Body site distribution of pediatric-onset morphea and association with extracutaneous manifestations.
Chiu YE; Shmuylovich L; Kiguradze T; Anderson K; Sibbald C; Tollefson M; Kunzler E; Tom WL; Bond K; Ahmad RC; Garcia-Romero MT; Irfan M; Kollman K; Hunt R; Stein SL; Arkin L; Wong V; Pope E; Jacobe H; Brandling-Bennett HA; Cordoro KM; Bercovitch L; Rangel SM; Liu X; Szabo A; Paller AS
J Am Acad Dermatol; 2021 Jul; 85(1):38-45. PubMed ID: 33689776
[TBL] [Abstract][Full Text] [Related]
3. Natural history and extracutaneous involvement of congenital morphea: Multicenter retrospective cohort study and literature review.
Mansour M; Liy Wong C; Zulian F; Li S; Morishita K; Yeh EA; Stewart K; Laxer RM; Pope E
Pediatr Dermatol; 2018 Nov; 35(6):761-768. PubMed ID: 30187959
[TBL] [Abstract][Full Text] [Related]
4. Localized scleroderma in childhood is not just a skin disease.
Zulian F; Vallongo C; Woo P; Russo R; Ruperto N; Harper J; Espada G; Corona F; Mukamel M; Vesely R; Musiej-Nowakowska E; Chaitow J; Ros J; Apaz MT; Gerloni V; Mazur-Zielinska H; Nielsen S; Ullman S; Horneff G; Wouters C; Martini G; Cimaz R; Laxer R; Athreya BH;
Arthritis Rheum; 2005 Sep; 52(9):2873-81. PubMed ID: 16142730
[TBL] [Abstract][Full Text] [Related]
5. Linear morphea: Clinical characteristics, disease course, and treatment of the Morphea in Adults and Children cohort.
Kunzler E; Florez-Pollack S; Teske N; O'Brien J; Prasad S; Jacobe H
J Am Acad Dermatol; 2019 Jun; 80(6):1664-1670.e1. PubMed ID: 31005342
[TBL] [Abstract][Full Text] [Related]
6. Morphea patients with mucocutaneous involvement: A cross-sectional study from the Morphea in Adults and Children (MAC) cohort.
Prasad S; Black SM; Zhu JL; Sharma S; Jacobe H
J Am Acad Dermatol; 2021 Jul; 85(1):114-120. PubMed ID: 33249064
[TBL] [Abstract][Full Text] [Related]
7. An Evaluation of the Performance of Current Morphea Subtype Classifications.
Prasad S; Zhu JL; Schollaert-Fitch K; Torok KS; Jacobe HT
JAMA Dermatol; 2021 Apr; 157(4):1-8. PubMed ID: 33595618
[TBL] [Abstract][Full Text] [Related]
8. Distinct autoimmune syndromes in morphea: a review of 245 adult and pediatric cases.
Leitenberger JJ; Cayce RL; Haley RW; Adams-Huet B; Bergstresser PR; Jacobe HT
Arch Dermatol; 2009 May; 145(5):545-50. PubMed ID: 19451498
[TBL] [Abstract][Full Text] [Related]
9. Extracutaneous involvement is common and associated with prolonged disease activity and greater impact in juvenile localized scleroderma.
Li SC; Higgins GC; Chen M; Torok KS; Rabinovich CE; Stewart K; Laxer RM; Pope E; Haines KA; Punaro M; O'Neil KM;
Rheumatology (Oxford); 2021 Dec; 60(12):5724-5733. PubMed ID: 33711155
[TBL] [Abstract][Full Text] [Related]
10. Remission rates and risk factors for relapse in pediatric morphea: a multicenter retrospective study of Pediatric Rheumatology Academy (PeRA)-Research Group (RG).
Bağlan E; Kızıldağ Z; Çağlayan Ş; Çakmak F; Yener GO; Özdel S; Öztürk K; Makay B; Çakan M; Ayaz NA; Sözeri B; Ünsal ŞE; Bülbül M
Clin Rheumatol; 2023 Oct; 42(10):2855-2860. PubMed ID: 37378874
[TBL] [Abstract][Full Text] [Related]
11. Comparison of outcomes in adults with pediatric-onset morphea and those with adult-onset morphea: a cross-sectional study from the morphea in adults and children cohort.
Condie D; Grabell D; Jacobe H
Arthritis Rheumatol; 2014 Dec; 66(12):3496-504. PubMed ID: 25156342
[TBL] [Abstract][Full Text] [Related]
12. Major histocompatibility complex class I and class II alleles may confer susceptibility to or protection against morphea: findings from the Morphea in Adults and Children cohort.
Jacobe H; Ahn C; Arnett FC; Reveille JD
Arthritis Rheumatol; 2014 Nov; 66(11):3170-7. PubMed ID: 25223600
[TBL] [Abstract][Full Text] [Related]
13. Clinical features of patients with morphea and the pansclerotic subtype: a cross-sectional study from the morphea in adults and children cohort.
Kim A; Marinkovich N; Vasquez R; Jacobe HT
J Rheumatol; 2014 Jan; 41(1):106-12. PubMed ID: 24293577
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory arthritis in pediatric patients with morphea.
Kashem SW; Correll CK; Vehe RK; Hobday PM; Binstadt BA; Maguiness SM
J Am Acad Dermatol; 2018 Jul; 79(1):47-51.e2. PubMed ID: 29535035
[TBL] [Abstract][Full Text] [Related]
15. Orthopedic complications of linear morphea: Implications for early interdisciplinary care.
Schoch JJ; Schoch BS; Werthel JD; McIntosh AL; Davis DMR
Pediatr Dermatol; 2018 Jan; 35(1):43-46. PubMed ID: 29119592
[TBL] [Abstract][Full Text] [Related]
16. The role of skin trauma in the distribution of morphea lesions: a cross-sectional survey of the Morphea in Adults and Children cohort IV.
Grabell D; Hsieh C; Andrew R; Martires K; Kim A; Vasquez R; Jacobe H
J Am Acad Dermatol; 2014 Sep; 71(3):493-8. PubMed ID: 24880663
[TBL] [Abstract][Full Text] [Related]
17. Morphea in adults and children cohort III: nested case-control study--the clinical significance of autoantibodies in morphea.
Dharamsi JW; Victor S; Aguwa N; Ahn C; Arnett F; Mayes MD; Jacobe H
JAMA Dermatol; 2013 Oct; 149(10):1159-65. PubMed ID: 23925398
[TBL] [Abstract][Full Text] [Related]
18. Morphea in adults and children cohort II: patients with morphea experience delay in diagnosis and large variation in treatment.
Johnson W; Jacobe H
J Am Acad Dermatol; 2012 Nov; 67(5):881-9. PubMed ID: 22382198
[TBL] [Abstract][Full Text] [Related]
19. Musculoskeletal MRI findings of juvenile localized scleroderma.
Eutsler EP; Horton DB; Epelman M; Finkel T; Averill LW
Pediatr Radiol; 2017 Apr; 47(4):442-449. PubMed ID: 28091699
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
